Search Results

Brian Krumm and Bryan Roth studied CryoEM structures of adhesion in GPCR CD97, filling gaps.

essential for developing new treatments for these disorders and advancing our understanding of the brain K ´ onigstorfer, M. Mozhayeva, Y. Sara, T.C. Südhof, and ¨ E.T. Kavalali. 2001.

extracellular signal-regulated kinases 1/2 (ERK1/2) signaling, p38 signaling, mitochondrial respiration and Na+/K+

CUB domain of the adhesion GPCR ADGRG6/GPR126 is a key regulator of receptor signaling Jiankun Lyu, Brian Shoichet, Bryan Roth, et al. for their research on AlphaFold2 structures guide prospective ligand discovery

fantastic paper on Development of Putative Bivalent Dicovalent Ligands for the Adenosine A1 Receptor Bryan Roth  and Brian Krumm  for their excellent study on Molecular glues as potential GPCR therapeutics Sabrina

Jang W, Senarath K, Feinberg G, Lu S, Lambert NA.

article Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling Sonja Peter , Brian

Sudha K Shenoy et al. perspectives of GPCR-based genetically encoded fluorescent indicators for neuromodulators Illuminating the brain-genetically

members of the RGS family are selective for certain GPCRs, as a proof RGS4 which is expressed in the brain Avrampou, K., et al., RGS4 Maintains Chronic Pain Symptoms in Rodent Models.

through G-protein-coupled receptors (GPCRs), fine-tune motoneuron (MN) IME by modulating background K+

Brian Arey, and Dr. J. Silvio Gutkind.

hydrogen-deuterium exchange (HDX) mass spectrometry for time-dependent conformational insights (Komolov, K. proteins, presenting an array of effectors that could be recruited to GPCR–β-arrestin complexes (Xiao, K

K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003).

Cell death signaling in Anopheles gambiae initiated by Bacillus thuringiensis Cry4B toxin involves Na+/K+

It wasn’t until his postdoctoral years at UCSF—under Brian Shoichet—that GPCRs entered his scientific

K., Hoppe, N., Huang, X.-P., Macdonald, C. B., Mehrotra, E., Patrick Rockefeller Grimes, Zahm, A.

BERKY consists of a membrane linker, a BRET donor, an ER/K α-helix linker, a BRET acceptor, and an active

full control of signaling activity through a small protein GPCR via library-based screening Dorgham, K. candidate hits from library-based screening so that they can be tested in cell-based assays Akondi, K. small proteins show full in vivo efficacy in a highly stringent model of HIV transmission Steinbach, K.

Live-tissue visualization Cell-type-specific receptor mapping Validation in both the periphery and brain effects are tied to where agonists bind Weight-loss and appetite effects often originate in precise brain This imaging tool is now being used to: Re-evaluate where GLP-1 and GIP receptors matter most Clarify brain

Bandekar with help from Nathan Zaidman and Abhishek K. Singh

a single sialic acid, although, in rare cases glycans can carry polysialylation (PolySia) (Mindler K

accordance with our findings demonstrating the prevalence of 5-HT2A–TrkB heteroreceptor complexes in these brain especially the striatum, demonstrating that the balance between TrkB and 5-HT2A may shift in certain brain heterodimerization and suggest that the regulated expression of 5-HT2A and TrkB is a molecular mechanism for the brain-region-specific

The blood-brain-barrier (BBB) and the complexity of the central nervous system (CNS) pose a challenge GPCR Structure, Activation, and Signaling Pathways in the Brain An understanding of GPCR structure is Greater specificity : allows for selective tracking of receptor subtypes in complex brain tissues.

D3.49R3.50Y3.51 motifs, located near the intracellular ends of TM7 and TM3, respectively (Weis and Kobilka

parallel pathways independently relay innate threat signals from different sensory modalities to multiple brain innate threat cues are integrated and conveyed from each sensory modality to the amygdala, a critical brain

September 2022 "Glutamate is the primary excitatory neurotransmitter in the brain and plays critical orthosteric and allosteric ligands acting on either mGluR2, mGluR3 or both for the management of these brain

September 2022 Cannabinoid type-2 receptors: An emerging target for regulating schizophrenia-relevant brain electrophysiological studies, indicate that CB2 receptors are expressed in specific dopaminergic and glutamatergic brain

GPCR Podcast: Visualizing GLP-1 & GIP Receptors in Islets and Brain Understanding incretin biology depends ligands to map receptor distribution, internalization, and engagement across pancreatic islets and brain

discovery programs in key therapeutic areas Kallyope, pioneers in drug discovery involving the gut-brain biopharmaceutical company, and New York City-based Kallyope, pioneers in drug discovery involving the gut-brain

Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumour in adults. Despite this, the prognosis remains poor, with an impacted quality of life during treatment coupled with brain